HR-positives HER2-negatives Mammakarzinom: Längeres Überleben unter CDK4/6-Inhibitor
Crossref DOI link: https://doi.org/10.1007/s15015-020-2459-2
Published Online: 2020-06-30
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Westphal, Kirsten
Text and Data Mining valid from 2020-06-01
Version of Record valid from 2020-06-01
Article History
First Online: 30 June 2020
Free to read: This content has been made available to all.